Peers Price Chg Day Year Date
Agilent 135.39 1.54 1.15% -8.91% Feb/02
Avanos Medical 13.47 0.15 1.13% -19.58% Feb/02
Bio-Rad Laboratories 297.43 3.73 1.27% -15.82% Feb/02
Danaher 223.42 4.53 2.07% 4.28% Feb/02
Integra LifeSciences 11.16 0.02 0.18% -57.08% Feb/02
Idexx Laboratories 639.60 -30.86 -4.60% 36.36% Feb/02
Illumina 141.12 -3.69 -2.55% 7.64% Feb/02
Neogen 10.25 0.03 0.29% -6.31% Feb/02
Quidel 27.65 0.48 1.77% -34.99% Feb/02
STAAR Surgical 18.04 -0.91 -4.80% -22.84% Feb/02

Indexes Price Day Year Date
USND 23592 130.29 0.56% 21.66% Feb/02
US2000 2641 26.94 1.03% 16.93% Feb/02

Neogen traded at $10.25 this Monday February 2nd, increasing $0.03 or 0.29 percent since the previous trading session. Looking back, over the last four weeks, Neogen gained 41.18 percent. Over the last 12 months, its price fell by 6.31 percent. Looking ahead, we forecast Neogen to be priced at 9.91 by the end of this quarter and at 9.02 in one year, according to Trading Economics global macro models projections and analysts expectations.

Neogen Corporation is a developer, manufacturer, and marketer of a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits, culture media and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides.